Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -183,659 | -344,874 | -423,139 | -287,439 | -168,822 |
| Depreciation Amortization | 754 | 16,395 | 11,055 | 5,812 | 2,136 |
| Accounts payable and accrued liabilities | -4,170 | -54 | 2,392 | 1,600 | -5,237 |
| Other Working Capital | -45,087 | 19,586 | 13,796 | -7,435 | -19,363 |
| Other Operating Activity | 78,848 | 148,459 | 93,429 | 84,819 | 82,937 |
| Operating Cash Flow | $-153,314 | $-160,488 | $-302,467 | $-202,643 | $-108,349 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -484 | -5,422 | -4,711 | -973 | -435 |
| Purchase Of Investment | -171,281 | -879,067 | -567,187 | -567,188 | -227,419 |
| Sale Of Investment | 25,000 | 567,500 | 255,000 | 52,500 | 0 |
| Investing Cash Flow | $-146,765 | $-316,989 | $-316,898 | $-515,661 | $-227,854 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 322,874 | 322,874 | 323,074 | N/A |
| Common Stock Issued | 2,588 | 392,416 | 386,099 | 384,973 | 383,267 |
| Other Financing Activity | -956 | -23,112 | -23,112 | -23,112 | 20,000 |
| Financing Cash Flow | $1,632 | $692,178 | $685,861 | $684,935 | $403,267 |
| Exchange Rate Effect | -1,611 | 359 | -1,666 | -20 | -152 |
| Beginning Cash Position | 567,045 | 351,985 | 351,985 | 351,985 | 351,985 |
| End Cash Position | 266,987 | 567,045 | 416,815 | 318,596 | 418,897 |
| Net Cash Flow | $-300,058 | $215,060 | $64,830 | $-33,389 | $66,912 |
| Free Cash Flow | |||||
| Operating Cash Flow | -153,314 | -160,488 | -302,467 | -202,643 | -108,349 |
| Capital Expenditure | -484 | -5,422 | -4,711 | -973 | -435 |
| Free Cash Flow | -153,798 | -165,910 | -307,178 | -203,616 | -108,784 |